proposed that inhibition of PI3K by wortmannin could repress growth of human tumor xenografts in mice (110), there have been more than 20 types of small-molecule inhibitors entering clinical trials and more than 50 types tested in laboratories. This evidence concerns the gene PIK3CB and neoplasm.